Mint-flavored chewing gum for treating nausea in pregnant women with hyperemesis gravidarum
The Effect of Mint Flavored Chewing Gum Application on Nausea Vomiting Severity, Coping With Stress and Anxiety Level in Pregnants With Hyperemesis Gravidarum
This study is testing if mint-flavored chewing gum can help pregnant women with severe nausea and vomiting feel better and reduce their stress and anxiety.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 78 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | T.c. Ordu Üni̇versi̇tesi̇ Academic / other |
| Locations | 1 site (Rize) |
| Trial ID | NCT06266819 on ClinicalTrials.gov |
What this trial studies
This clinical trial investigates the effects of mint-flavored chewing gum on the severity of nausea and vomiting, as well as stress and anxiety levels in pregnant women diagnosed with hyperemesis gravidarum. Participants will be randomly assigned to either an intervention group, receiving routine treatment plus the gum, or a control group, receiving only routine treatment. Data will be collected through various scales assessing nausea, stress coping styles, and anxiety before and after the intervention. The study aims to provide insights into a potential complementary treatment for this condition.
Who should consider this trial
Good fit: Ideal candidates are pregnant women aged 18 and over, married, diagnosed with hyperemesis gravidarum, and less than 16 weeks pregnant.
Not a fit: Patients with chronic diseases, those experiencing nausea from other health issues, or individuals allergic to mint may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could offer a simple and effective way to alleviate nausea and improve the quality of life for pregnant women suffering from hyperemesis gravidarum.
How similar studies have performed: While the use of chewing gum for nausea is not widely studied, similar interventions have shown promise in alleviating nausea in other contexts, suggesting potential for success.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Pregnant women aged 18 and over * At least primary school graduate * The one who is married * Pregnant women who are younger than 16 weeks of gestation and diagnosed with hyperemesis * Those who agreed to participate in the study Exclusion Criteria: * Those with a history of chronic disease * Having a health problem that may cause nausea and vomiting in the current pregnancy * Those who are allergic to mint
Where this trial is running
Rize
- Özel Şar Hospital — Rize, Turkey (Recruiting)
Study contacts
- Study coordinator: leyla emirik
- Email: leylayaguz@gmail.com
- Phone: +90 5062848323
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.